Skip Content
You are currently on the new version of our website. Access the old version .
IJMSInternational Journal of Molecular Sciences
  • Review
  • Open Access

20 February 2020

Endocrine-Disrupting Chemicals in Human Fetal Growth

and
1
Department of Mother and Child, 42123 Azienda USL–IRCCS di Reggio Emilia, Italy
2
Microbiome Research Hub, University of Parma, Via A. Catalani 10, 43123 Parma, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Advances in the Research of Endocrine Disrupting Chemicals 2.0

Abstract

Fetal growth is regulated by a complex interaction of maternal, placental, and fetal factors. The effects and outcomes that chemicals, widely distributed in the environment, may have on the health status of both the mother and the fetus are not yet well defined. Mainly mixtures of chemical substances are found in the mothers and placenta. Exposure to endocrine-disrupting chemicals (EDCs) can be associated with fetal growth retardation, thyroid dysfunction, and neurological disorders. EDCs mostly interfere with insulin, glucocorticoid, estrogenic, and thyroid pathways, with subsequent effects on normal endocrine and metabolic functions, which cause changes in the epigenome and state of inflammation with life-long effects and consequences. International scientific societies recommend the implementation of research and of all possible preventive measures. This review briefly summarizes all these aspects.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.